Dillard's, Inc. (DDS)
Last Price$366.0(2.8%)
Market Cap$5,872.5M
DDS Rating
DDS Quality rating performance
DDS Intrinsic Value
Key Highlights:
As of Mar 11, 2025 DDS Relative Value is $329.5, which is overvalued by 10.0%, compared to current share price of $366.0.
As of Mar 11, 2025 DDS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $366.0.
DDS Share Price History
1W (0.4%)
1M (26.9%)
6M 15.4%
YTD (4.3%)
1Y (4.7%)
3Y 59.9%
5Y 948.4%
10Y 261.5%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
DDS Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$5,872.5M
$5,184.2M
$6,531.1M
$260.3M
Shares Outstanding
16M
Employees
N/A
Growth (CAGR)
0.6%
65.7%
53.22%
(0.1%)
(0.1%)
(27.84%)
Profitability
58.7%
32.0%
5.3%
4.0%
68.7%
Intrinsic Value
$324.9 (11.2% overvalued)
N/A
$324.9
($804.6)
($659.7)
296.1%
Return on Capital
Financial Health
$1,043.6M
($688.3M)
(2.6x)
(1,162.8x)
15.1%
Dividends
14.6%
0.2%
4.7%
Mar 31, 2025
Earnings
Aug 13, 2025
BEAT by 26.0%
BEAT by 28.3%
44.9%
9 Beat & 1 Miss
DDS Stock Financials
DDS Income Statement Metrics
Annual
Quarterly
LTM
DDS Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$714.1M -60.5% YoY
Capital Expenditure (CAPEX)
($104.6M) -33.0% YoY
Free Cash Flow (FCF)
$609.5M -65.3% YoY
DDS Income Statement Overview
Annual
Quarterly
LTM
Jan'16
Jan'17
Feb'18
Feb'19
Feb'20
Jan'21
Jan'22
Jan'23
Feb'24
Feb'25
$6,482.6M (5.7%) YoY
Pre-tax income
$729.7M (20.4%) YoY
11.3% margin
DDS Balance Sheet Overview
Annual
Quarterly
LTM
Jan'16
Jan'17
Feb'18
Feb'19
Feb'20
Jan'21
Jan'22
Jan'23
Feb'24
Feb'25
Assets
Liabilities
Total assets
N/A
Current assets (N/A, N/A of total)
Non-current assets (N/A, N/A of total)
N/A (N/A)
N/A (N/A)
N/A (N/A)
Other non-current assets
N/A (N/A)
Financial position
$0.0
Cash & Short-term
Investments
Total Debt
DDS Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
DDS Earnings Surprises
Crunching data... Almost there!
DDS Dividends
DDS Dividend Yield
Crunching data... Almost there!
DDS Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with DDS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$5,872.5M | 7.3 | $324.9 11.2% overvalued | (4.7%) | $6,531.1M | $260.3M | (5.0%) | 4.0% | 58.7% | 101.4% | 15.1% | |
$79.3B | 7.2 | $50.3 59.9% overvalued | (23.0%) | $11.1B | $4,518.0M | 11.9% | 40.7% | 77.5% | 27.9% | 27.3% | |
$4,800.4M | 6.0 | $739.2 199.3% undervalued | 17.3% | $17.2B | $443.4M | 16.1% | 2.6% | 16.8% | 9.8% | 0.0% | |
$4,002.8M | 5.0 | $24.3 0.2% undervalued | 42.0% | $15.0B | $50.0M | 2.2% | 0.3% | 0.5% | (82.8%) | 146.1% | |
$3,816.9M | 5.3 | $23.1 68.8% undervalued | (30.5%) | $23.4B | $224.0M | (2.7%) | 1.0% | 40.9% | 12.9% | 140.5% | |
$2,204.8M | 4.5 | $161.1 341.2% undervalued | (50.9%) | $10.2B | ($96.2M) | (9.3%) | (0.9%) | 37.1% | (8.6%) | 169.9% | |
$1,021.8M | 4.4 | $29.2 219.4% undervalued | (62.8%) | $16.2B | $52.0M | (7.2%) | 0.3% | 26.5% | 3.6% | 38.1% | |
$833.7M | 6.1 | $16.4 65.2% undervalued | (12.8%) | $1,231.0M | $54.7M | 5.2% | 4.4% | 30.8% | 14.3% | 13.3% | |
$562.9M | 4.7 | $37.6 982.3% undervalued | (35.4%) | COP 21.9T | (COP 96.5B) | 3.6% | (0.4%) | 23.9% | 10.1% | 52.9% | |
$413.4M | 6.9 | $647.8 2,387.8% undervalued | 7.3% | $6,482.6M | $260.3M | (4.0%) | 4.0% | 100.0% | 146.8% | 15.1% | |
$169.1M | 4.7 | $3.9 617.3% undervalued | (50.0%) | R$18.8B | R$84.0M | (0.4%) | 0.4% | 23.0% | 2.3% | 211.9% |
FAQ
What is Dillard's, Inc. (DDS) stock rating?
As of today, Dillard's, Inc. has a stock rating of 7 (out of 10), which is considered Great.
is Dillard's, Inc. (DDS) a good stock to buy?
As of today, Dillard's, Inc. has a Great stock rating, which is 11.2% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.